FDA's Official Reasons: Lack of Clinical Trials: The FDA emphasizes the need for extensive, controlled clinical trials, which are currently lacking
Multivitamins should be viewed as an insurance policy rather than a replacement for food, Brown explains
In 2025, the company reported a +2.39% YoY growth in revenue, reflecting portfolio concentration: Biktarvy ($14.33B) continues to dominate the HIV segment with strong patient uptake, Descovy ($2.75B) remains a key contributor in both treatment and prevention, while Genvoya ($1.49B) continues its gradual decline as patients transition to newer regimens - highlighting a shift within its HIV portfolio
See our tirzepatide dosing guide and ozempic alternatives guides
The 4 mg dose delivered 15.2% weight loss with noticeably fewer side effects
The standard MIC B12 protocol begins with a weekly 1ml dose, which provides optimal energy and weight loss benefits for most patients [9]